4522
4523
4524
4525
4526
4527
4528
4529
4530
4531
4532
4533
4534
4535
4536
4537
4538
4539
4540
Home
En
中文
WebSite
> New Products
New Products
4522
4523
4524
4525
4526
4527
4528
4529
4530
4531
4532
4533
4534
4535
4536
4537
4538
4539
4540
945228-48-8
Oportuzumab Monatox
910649-32-0
Anrukinzumab
905703-97-1
Ganitumab
1821161-32-3
4-Bromo-1-isopropylisoquinoline
1824460-59-4
2-Chloro-4-isopropyl-6,7-dihydro-5H-cyclopenta[d]pyrimidine
2323574-78-1
(S)-2-Hydroxy-3-(tritylthio)propanoic Acid
173322-88-8
2-Amino-4-fluoro-5-methylphenol
2287316-98-5
1-(Chloromethyl)-3-(p-tolyl)bicyclo[1.1.1]pentane
191108-09-5
4,8,11-Tris-Boc-1,4,8,11-tetraazacyclotetradecane-1-acetic Acid
1240300-39-3
7-Formyl-6-hydroxybenzothiazole-2-carbonitrile
1247847-63-7
Perchlorophenyl (E)-3-[4-(Phosphonooxy)phenyl]-2-butenoate
1779417-82-1
3-Methyl-2,5-dioxoimidazolidine-4-carbaldehyde
2006263-62-1
Methyl 2-Methyl-7-oxo-6,7-dihydro-6-azaindole-4-carboxylate
2120518-85-4
3-Bromo-7-fluoro-1-methylindole
1214100-05-6
2-[2-[[1-(4-Chlorophenyl)ethyl]amino]propanamido]thiophene-3-carboxamide
15754-53-7
Bis(4-bromophenyl)phosphine Oxide
103440-91-1
2’-Hydroxy-4’-methyl-5’-nitroacetophenone
2216751-26-5
Cosibelimab
2171061-85-9
Nidanilimab
2098636-09-8
Nimacimab
2119595-80-9
Teclistamab
2097104-58-8
Spesolimab
1895083-75-6
Omburtamab
1912424-97-5
Enapotamab Vedotin
2050478-92-5
Cetrelimab
1796570-08-5
Netakimab
2108782-45-0
Narsoplimab
1629760-28-6
Ladiratuzumab
1858168-59-8
Tislelizumab
1831128-32-5
Lacnotuzumab
1807954-17-1
Gedivumab
1640972-00-4
Lupartumab Amadotin
1798286-48-2
Camrelizumab
1584645-37-3
Rozanolixizumab
1608108-91-3
Birtamimab
1452387-69-7
Crotedumab
1417158-65-6
Xentuzumab
1613313-01-1
Rovalpituzumab
1463459-96-2
Ascrinvacumab
1453362-55-4
Lilotomab
1531594-08-7
Tesidolumab
1448327-63-6
Lumretuzumab
1365287-97-3
Emibetuzumab
1326232-46-5
Anifrolumab
1359940-55-8
Tarextumab
1312299-39-0
Concizumab
945781-29-3
Placulumab
1228538-47-3
Quilizumab
1238517-16-2
Indatuximab Ravtansine
1133766-06-9
Onartuzumab
909875-08-7
Enokizumab
1011710-99-8
Iodine (124I) Girentuximab
1006877-41-3
Sifalimumab
336801-86-6
Vapaliximab
339986-90-2
Tucotuzumab Celmoleukin
1381841-36-6
Ticagrelor Impurity 129
188444-66-8
N-[2-(Naphthalen-2-yloxy)ethyl]-4-nitrobenzenesulfonamide
2222997-57-9
tert-Butyl 3-[3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]piperidine-1-carboxylate
1824116-57-5
2-(4-Aminocyclohexyl)-1,1,1-trifluoro-2-propanol
861926-74-1
(4,5-Dimethyl-2-furyl)tributylstannane
1800550-07-5
2-Bromo-6,6-dimethyl-5,6-dihydrobenzothiophen-7(4H)-one
2287191-39-1
(S)-2-(Bromomethyl)-1,4-dioxane
1097921-48-6
2-Isopropoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidyl]aniline
1213269-25-0
5-Chloro-N-[2-methoxy-4-(4-methyl-1-piperazinyl)phenyl]-4-(3-nitrophenoxy)pyrimidin-2-amine
879887-39-5
6-Bromo-2-isopropyl-3,4-dihydroisoquinolin-1(2H)-one
2098065-88-2
1-Cyclopentyl-4-ethynylpyrazole
14255-36-8
1-(2-Methyl-1,3-dioxolan-2-yl)-2-propanone
2205097-55-6
4-Chloro-2,8-dimethyl-1,7-naphthyridine
161773-56-4
(R)-7a-Allyl-2,3,7,7a-tetrahydro-1H-indene-1,5(6H)-dione
2211116-05-9
(2R,3S,4R)-1-Boc-3-fluoro-4-hydroxypyrrolidine-2-carboxylic Acid
1635395-25-3
Tavolimab
2206792-50-7
Sasanlimab
2225940-98-5
Ivuxolimab
2185868-98-6
Disitamab
2171034-70-9
Relfovetmab
2166339-33-7
Cetuximab Sarotalocan
2101829-58-5
Glenzocimab
1924598-82-2
Toripalimab
2095467-30-2
Rolinsatamab
2061894-48-0
Belantamab
2044679-53-8
Tepoditamab
1399584-78-1
Romilkimab
2050232-20-5
Belantamab Mafodotin
1918185-84-8
Tiragolumab
1905409-39-3
Mosunetuzumab
1792982-55-8
Porgaviximab
1826843-81-5
Trastuzumab Deruxtecan
1642152-40-6
Trastuzumab Duocarmazine
1632282-27-9
Ranevetmab
1585973-65-4
Depatuxizumab Mafodotin
1436390-63-4
Vadastuximab
1523164-68-2
Prezalumab
1391726-30-9
Landogrozumab
1572943-04-4
Tezepelumab
1299440-37-1
Inebilizumab
1401965-15-8
Bermekimab
1422527-84-1
Tafasitamab
1229575-09-0
Lenzilumab
1105038-73-0
Abituzumab
1357158-22-5
Fletikumab
MSDS
|
CAS
|
CAS DataBase
|
Pricacy
|
Terms
|
About Us
|
New Products
|
Contact us
|
Computer Version
Chemical Book